Wednesday, November 13, 2019

REPORTING FROM AN FDA ADVISORY COMMITTEE MEETING


A Food and Drug Administration advisory panel voted 14-2 against recommending approval of a supplemental New Drug Application for empagliflozin (Jardiance) as an adjunct to insulin therapy to improve glycemic control in adults with type 1 diabetes. The drug is already is approved for people with type 2 diabetes.
Be well.

DrD
Academician Dorodny, Dorodny, Prof, Dorodny, NEW Institute, myths, , Dr.Dorodny, Victor Dorodny MD, mythology, investigative Mythologist, TRI-PAC, health consumer advocacy, medical/heath investigative mythology, medical myths, skin patches, inhaled, inhaled vitamins, PatchMD.com, health myths, healtcarING, health carING, PatchMD, PatchMD.com, Medical Scientist, Chief Medical Scientist, Investigative Medical Mythologist, Editor-in-Chief AMHSR, DrD, Dr.D, DrD's, Mobility Scooters, www.thehouseofscooters.com, Victor Dorodny, AmazingDrD, #AmazingDrD, assisted mobility scooters, scooters, golden milk,turmeric, coconut oil, honey, cinnamon, cayanne pepper, dialing 911,

No comments: